AstraZeneca combo therapy shows breakthrough in liver cancer trial
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases
This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams
Subscribe To Our Newsletter & Stay Updated